General
Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions
Published at 9 April 2026 at 11:39Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Board of Directors' decisions held on 08/04/2026.
The BoD Decisions (282 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
The Board of Directors' decisions held on 08/04/2026.
The BoD Decisions (282 KB)